M B Vidriales
Overview
Explore the profile of M B Vidriales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Vidriales M, Anderson K
Mol Med Today
. 1996 Oct;
2(10):425-31.
PMID: 8897437
Multiple myeloma is characterized by excess plasma cells within the bone marrow in association with monoclonal antibody protein in the serum and/or urine. Tumor cells localize within the marrow via...
12.
Urashima M, Ogata A, Chauhan D, Vidriales M, Teoh G, Hoshi Y, et al.
Blood
. 1996 Sep;
88(6):2219-27.
PMID: 8822942
Interleukin-6 (IL-6) mediates autocrine and paracrine growth of multiple myeloma (MM) cells and inhibits tumor cell apoptosis. Abnormalities of retinoblastoma protein (pRB) and mutations of RB gene have been reported...
13.
Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales M, Dedera D, et al.
Blood
. 1996 Mar;
87(5):1928-38.
PMID: 8634441
Interleukin-6 (IL-6), a product of bone marrow stromal cells (BMSCs), is a growth factor for multiple myeloma (MM) cells. Transforming growth factor-beta1 (TGF-beta1) is also produced by BMSCs and can...
14.
Macedo A, San Miguel J, Vidriales M, Lopez-Berges M, Garcia-Marcos M, Gonzalez M, et al.
J Clin Pathol
. 1996 Jan;
49(1):15-8.
PMID: 8666678
Aim: To explore the role of phenotypic changes as possible limiting factors in the immunological detection of minimal residual disease in patients with acute myeloid leukaemia (AML). Methods: 20 relapses...
15.
Macedo A, Orfao A, Gonzalez M, Vidriales M, Lopez-Berges M, Martinez A, et al.
Leukemia
. 1995 Jun;
9(6):993-8.
PMID: 7596191
The aim of the present study was to analyze the incidence of AML cases displaying more than one blast cell subpopulation by immunophenotype at diagnosis, since, any of them, although...
16.
Vidriales M, Orfao A, Lopez-Berges M, Gonzalez M, Garcia M, Galende J, et al.
J Clin Pathol
. 1995 May;
48(5):456-62.
PMID: 7629293
Aims: To analyse the forward scatter/side scatter (FSC/SSC) distribution of acute myeloblastic leukaemia (AML) blast cells in order to assess whether it correlates with their morphology, immunophenotype, and clinical and...
17.
Macedo A, Orfao A, Vidriales M, Lopez-Berges M, VALVERDE B, Gonzalez M, et al.
Ann Hematol
. 1995 Apr;
70(4):189-94.
PMID: 7748963
The existence of leukemic-associated phenotypes has been suggested to be a valuable tool for the detection of minimal residual disease (MRD) in AML patients, as they would allow to distinguish...
18.
Vidriales M, Orfao A, Lopez-Berges M, Gonzalez M, Ciudad J, Lopez A, et al.
Cytometry
. 1995 Mar;
22(1):22-5.
PMID: 7587729
In the present study the DNA cell content of 205 de novo acute myeloblastic leukemia (AML) patients is analyzed at flow cytometry in order to determine both the incidence of...
19.
Vidriales M, Orfao A, Lopez-Berges M, Gonzalez M, Ciudad J, Lopez A, et al.
Br J Haematol
. 1995 Feb;
89(2):342-8.
PMID: 7873384
Until now, reports on the cell cycle distribution of AML patients have shown highly variable results which are probably related to the technical heterogeneity of such studies. The aim of...
20.
Macedo A, Orfao A, Martinez A, Vidriales M, VALVERDE B, Lopez-Berges M, et al.
Br J Haematol
. 1995 Feb;
89(2):338-41.
PMID: 7532985
In the present study, seven normal human bone marrow samples from healthy volunteers have been analysed in order to investigate the immunophenotypic characteristics of the normal CD117+ cells and their...